| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Blood Systems is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Westwood Health Care Ctr is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
United Home Health Services is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.